J. Goldman & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$84.2M |
| 2 |
VG
Vonage Holdings Corporation
VG
|
+$35.7M |
| 3 |
Cognizant
CTSH
|
+$31M |
| 4 |
Caleres
CAL
|
+$26M |
| 5 |
FL
Foot Locker
FL
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ralph Lauren
RL
|
+$37.2M |
| 2 |
NETGEAR
NTGR
|
+$26.9M |
| 3 |
Walmart Inc
WMT
|
+$17.4M |
| 4 |
Collegium Pharmaceutical
COLL
|
+$13.3M |
| 5 |
STNL
Sentinel Energy Services Inc. Class A Common Stock
STNL
|
+$13.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.88% |
| 2 | Communication Services | 13.06% |
| 3 | Technology | 7.1% |
| 4 | Industrials | 6.46% |
| 5 | Healthcare | 5.82% |
Similar funds
J. Goldman & Co's Q1 2019 Portfolio in Review
As of Q1 2019, J. Goldman & Co held 375 positions worth $1.77B, up 37% from $1.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
J. Goldman & Co deployed $459M of net new capital in Q1 2019, opening 143 new positions and adding to 47 existing holdings. Its largest new stake was Vonage Holdings Corporation: 3,722,294 shares worth $37.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Collegium Pharmaceutical, an estimated $13.3M trimmed.
- J. Goldman & Co's largest Q1 2019 buy was Vonage Holdings Corporation: 3,722,294 shares worth $37.4M.
- J. Goldman & Co added most to Walt Disney in Q1 2019, an estimated $84.2M increase.
- J. Goldman & Co's biggest Q1 2019 reduction was Collegium Pharmaceutical, cutting an estimated $13.3M.
- J. Goldman & Co fully exited Ralph Lauren in Q1 2019, selling an estimated $37.2M.
- J. Goldman & Co's ten largest holdings make up 27% of its $1.77B portfolio in Q1 2019.
- J. Goldman & Co opened 143 new positions and closed 115 in Q1 2019.
- J. Goldman & Co's portfolio value rose 37% quarter-over-quarter to $1.77B.
Based on J. Goldman & Co's 13F filing for Q1 2019, filed 14 May 2019.